Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02367859
Title Dabrafenib and Trametinib in Treating Patients With BRAF Mutated Ameloblastoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Stanford University
Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST